Literature DB >> 29468059

Oxaliplatin-induced hepatic sinusoidal obstruction syndrome in a patient with gastric cancer: A case report.

Fang Liu1, Xin Cao2, Jin Ye2, Xiaoli Pan2, Xuefeng Kan3, Yuhu Song2.   

Abstract

Oxaliplatin is a platinum-based antineoplastic agent used in cancer chemotherapy. Oxaliplatin-induced hepatic sinusoidal obstruction syndrome (HSOS) has been reported in the context of chemotherapy for liver metastasis of colorectal cancer. However, to the best of our knowledge, there is no report of oxaliplatin-associated HSOS in patients with gastric cancer. The present study reported a patient with gastric cancer who received proximal gastrectomy and oxaliplatin-containing chemotherapy. Contrast-enhanced computed tomography revealed that liver parenchyma appeared heterogeneous and demonstrated hypoattenuation in the portal phase. In dynamic contrast-enhanced magnetic resonance imaging, hypointense heterogeneity was demonstrated in the portal-venous phase. Pathological examination indicated distinctive multifocal sinusoidal dilatation. In conclusion, the present report indicated a case of oxaliplatin-induced HSOS in a patient with gastric cancer who received oxaliplatin-contained chemotherapy.

Entities:  

Keywords:  hepatic sinusoidal obstruction syndrome; oxaliplatin; sinusoidal obstruction syndrome

Year:  2017        PMID： 29468059      PMCID： PMC5791411          DOI： 10.3892/mco.2017.1540

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN： 2049-9450


  18 in total

Review 1.  Management of hepatic vascular diseases.

Authors:  Aurélie Plessier; Pierre-Emmanuel Rautou; Dominique-Charles Valla
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

Review 2.  Liver sinusoidal endothelial cells and liver regeneration.

Authors:  Laurie D DeLeve
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

Review 3.  Sinusoidal obstruction syndrome (hepatic veno-occlusive disease).

Authors:  Cathy Q Fan; James M Crawford
Journal:  J Clin Exp Hepatol       Date:  2014-10-30

4.  Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases.

Authors:  Na-Young Shin; Myeong-Jin Kim; Joon Seok Lim; Mi-Suk Park; Yong-Eun Chung; Jin-Young Choi; Ki Whang Kim; Young-Nyun Park
Journal:  Eur Radiol       Date:  2011-11-23       Impact factor: 5.315

5.  Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

Authors:  L Rubbia-Brandt; V Audard; P Sartoretti; A D Roth; C Brezault; M Le Charpentier; B Dousset; P Morel; O Soubrane; S Chaussade; G Mentha; B Terris
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

Review 6.  Sinusoidal obstruction syndrome.

Authors:  Dominique-Charles Valla; Dominique Cazals-Hatem
Journal:  Clin Res Hepatol Gastroenterol       Date:  2016-03-30       Impact factor: 2.947

7.  Chemotherapy-induced focal hepatopathy in patients with gastrointestinal malignancy: gadoxetic acid--enhanced and diffusion-weighted MR imaging with clinical-pathologic correlation.

Authors:  Na Yeon Han; Beom Jin Park; Deuk Jae Sung; Min Ju Kim; Sung Bum Cho; Chang Hee Lee; Yun-Jin Jang; So Yeon Kim; Dong Sik Kim; Soon Ho Um; Nam Hee Won; Kyung Sook Yang
Journal:  Radiology       Date:  2014-01-16       Impact factor: 11.105

8.  The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015.

Authors:  Giovanni De Manzoni; Daniele Marrelli; Gian Luca Baiocchi; Paolo Morgagni; Luca Saragoni; Maurizio Degiuli; Annibale Donini; Uberto Fumagalli; Maria Antonietta Mazzei; Fabio Pacelli; Anna Tomezzoli; Mattia Berselli; Filippo Catalano; Alberto Di Leo; Massimo Framarini; Simone Giacopuzzi; Luigina Graziosi; Alberto Marchet; Mario Marini; Carlo Milandri; Gianni Mura; Elena Orsenigo; Vittorio Quagliuolo; Stefano Rausei; Riccardo Ricci; Fausto Rosa; Giandomenico Roviello; Andrea Sansonetti; Giovanni Sgroi; Guido Alberto Massimo Tiberio; Giuseppe Verlato; Carla Vindigni; Riccardo Rosati; Franco Roviello
Journal:  Gastric Cancer       Date:  2016-06-02       Impact factor: 7.370

9.  Oxaliplatin-induced sinusoidal obstruction syndrome mimicking metastatic colon cancer in the liver.

Authors:  Jung-Hye Choi; Young-Woong Won; Hyun Sung Kim; Young-Ha Oh; Sanghyeok Lim; Han-Joon Kim
Journal:  Oncol Lett       Date:  2016-02-29       Impact factor: 2.967

10.  Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome.

Authors:  Xuefeng Kan; Jin Ye; Xinxin Rong; Zhiwen Lu; Xin Li; Yong Wang; Ling Yang; Keshu Xu; Yuhu Song; Xiaohua Hou
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379
View more
  8 in total

1.  Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin-based chemotherapy.

Authors:  Shinichiro Kobayashi; Sadayuki Okudaira; Kazuma Kobayashi; Kengo Kanetaka; Susumu Eguchi
Journal:  Clin Case Rep       Date:  2019-01-09

2.  Sinusoidal obstruction syndrome: A systematic review of etiologies, clinical symptoms, and magnetic resonance imaging features.

Authors:  Yun Zhang; Han-Yu Jiang; Yi Wei; Bin Song
Journal:  World J Clin Cases       Date:  2019-09-26       Impact factor: 1.337

Review 3.  Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.

Authors:  Xiao-Qian Yang; Jin Ye; Xin Li; Qian Li; Yu-Hu Song
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

4.  Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study.

Authors:  Fang Liu; Xinxin Rong; Hui Guo; Dong Xu; Chang Liu; Lingling Meng; Xiaoqian Yang; Tingting Guo; Xuefeng Kan; Yuhu Song
Journal:  BMC Gastroenterol       Date:  2020-02-04       Impact factor: 3.067

5.  Prognostic factors for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: a multicenter study in China.

Authors:  Haitao Shang; Tao Bai; Shenghua Zhu; Xiaoqian Yang; Chang Liu; Dong Xu; Yuzheng Zhuge; Yuhu Song; Xiaohua Hou
Journal:  Ann Transl Med       Date:  2021-01

6.  Safety Profile of Oxaliplatin in 3,687 Patients With Cancer in China: A Post-Marketing Surveillance Study.

Authors:  Zaoqin Yu; Rui Huang; Li Zhao; Ximin Wang; Xiaofang Shangguan; Wei Li; Min Li; Xianguo Yin; Chengliang Zhang; Dong Liu
Journal:  Front Oncol       Date:  2021-10-21       Impact factor: 6.244

7.  Living donor liver transplantation for idiopathic portal hypertension with focal nodular hyperplasia.

Authors:  Yoshiaki Tanji; Kenei Furukawa; Yosuke Igarashi; Mitsuru Yanagaki; Koichiro Haruki; Yoshihiro Shirai; Tomohiko Taniai; Takeshi Gocho; Norimitsu Okui; Toru Ikegami
Journal:  Surg Case Rep       Date:  2022-04-21

8.  Unusual cause of lesions in the descending duodenum and liver: A case report and review of literature.

Authors:  Zhuang-Long Xiao; Ke-Shu Xu; Yu-Hu Song
Journal:  World J Clin Cases       Date:  2018-10-06       Impact factor: 1.337
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.